International Journal of Pharmacovigilance
ISSN Online :  2476-2431
Current Issue :  Volume1-Issue2 - 2016
Publisher :  Symbiosis Open access
Email :  pharmacovigilance@symbiosisonline.org
Additional Information    : Submit ManuscriptArchive Current Issue Editorial Board

About Journal

International Journal of Pharmacovigilance (IJP) is an International peer- reviewed open access Journal which aims to provide a platform to publish high quality research articles related to medical drugs. The main purpose of this Journal is to deliver information regarding the safety, efficacy, side effects, adverse effects and toxicity of the new interventional drug. The data published will provide an in depth knowledge to know the risk/benefits of the upcoming drug and thus it creates awareness in the society. The Journal will bridge the gap between the scientist and the readers.

Pharmacy industries are booming by manufacturing lot of drugs in the market. Now bio similar products, which are the copy of the original drug, are gaining more importance in medical science and pharma industry. These drugs have to undergo animal studies for toxicity check and clinical studies for the assessment of immunogenicity and pharmacokinetics/pharmacodynamics before the drug enters the market. Clinical trials are mainly carried out to see the safety, efficacy and purity of the new drug. Symbiosis online Journal of Pharmacovigilance will definitely provide the society with the upcoming research and also provides a podium for the scientist, researchers, students and academicians to broadcast their novel research in order to discuss and share the issues related with the drug.

The scope of the Journal includes topics related to pharmacovigilance data management, drug design, drug development, principles of pharmacology, pharmacovigilance signal, software, ethics and regulations related to pharmacovigilance, pharmaceutical drugs, side effects and diagnosis of drugs, clinical trial reports etc.

Symbiosis online Journal of pharmacovigilance welcomes authors to publish their ground breaking research in the form of original articles, clinical case reports, mini reviews, review articles, short communications, editorials and opinion articles related to the clinical features, epidemiology and adverse effect assessment and management of inventor drugs and its subclasses . The Journal will furnish a wide array of facts and materials about the upcoming drug to use in a specified therapeutic function thereby improving the safe and valid use of medicines. All the submitted manuscripts will be thoroughly peer- reviewed before publication and the accepted articles will be published online immediately and can be accessed throughout the world without any restrictions and subscriptions.

Financial Aid

Symbiosis • Grants
• Scholarships
• Waivers



Read More

Support Us

Open access • Associate with us
• Collaborate with us
• Advertise with us
• Membership
• Sponsors
• Donors
Read More

 
Listing : ICMJE   

Creative Commons License Open Access by Symbiosis is licensed under a Creative Commons Attribution 3.0 Unported License